My question is how can a study be done stating that any drug can delay progression of RRMS when everyone's MS is different and you cannot predict when you are going to have an attack?
Personally, IMO, it's very hard and I have not found any convincing evidence or studies to suggest that in fact the CRABs delay progression.
Most Phase III studies are of 2 years duration, everyone's MS is different as you said, and MS lasts a life time once you're diagnosed. I think the CRABs have been approved by the FDA on the basis that for some people they reduce the number of relapses, not necessarily delay progression (although the pharmaceutical companies would try to convince you otherwise
If someone has seen some research indicating any of the CRABs significantly delay progression for a large percentage of people with MS I'd love to learn about it.
You're not alone Alicia--I think a good number of us are probably frustrated right along with you.